期刊文献+

EP、DP方案加同步放疗治疗局部晚期非小细胞肺癌观察 被引量:2

Clinical Observation of EP,DP Regimen Combined with Radiotherapy in Treatment of Locally Advanced Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的EP、DP方案加同步放疗治疗晚期非小细胞肺癌的疗效,毒副反应及耐受性观察。方法91例局部晚期非小细胞肺癌患者随机分为两组:EP方案加同步放疗46例,DP方案加同步放疗45例。放疗均采用钴60γ线常规分割照射。结果EP化放组、DP化放组有效率分别为52.2%、71.1%,但差异统计学意义(P>0.05)。两组完全缓解率分别为10.9%(5/46)、28.9%(13/45),两组比较差异有统计学意义。两组1、2年生存率分别为45.3%、62.4%和20.2%、32.6%。主要副反应为胃肠道反应、骨髓抑制、脱发,DP组较重,大部分病人可以耐受,无治疗相关性死亡。结论两方案同步放化疗治疗均可用于局部晚期非小细胞肺癌的一线综合治疗。 Objective To observe the effect and the clinical toxicity between EP, DP regimen combined with concurrent radiotherapy in the treatment of locally advanced no,small cell lung cancer(NSCLC). MethodsNinety-one patients were randomly assigned into two groups . EP group: EP regimen concurrent radiotherapy for 46 cases, DP group: DP regimen concurrent radiotherapy for 45 cases, radiotherapy are conventional standard fractionation. Results The response rate in EP group and DP group were 52. 2%, 71.1% respectively(P〉0. 05). The local complete response rate were 10. 9% (5/46),28. 9% (13/45) for the patients treated with EP,DP regimen respectively (P〈0. 05). One year survival rate in EP,DP group were 45.3%,62.4% respectively. Two year survival rate wrer 20. 2% and 32. 6%o. The major toxicity was gastrointestinal tract reaction, myelosuppression and alopecia and so on. Most of patients tolerate well. Conclusion EP,DP regimen concurrent radiotherapy has good clinical efficacy and safe in the com- bined therapy of locally advanced NSCLC. They could become the original regimen in locally advanced NSCLC.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2008年第9期662-664,共3页 Cancer Research on Prevention and Treatment
关键词 晚期非小细胞肺癌 化疗 放疗 多西他赛 顺氯氨铂 Advanced non-small cell lung cancer Chemotherapy Radiotherapy Docetaxel Cisplatin
  • 相关文献

参考文献5

二级参考文献41

共引文献64

同被引文献14

  • 1戚好文,叶江枫,宋立强,陈卫强,梁军,穆德广.血清内皮素-1作为早期放射性肺损伤标志物的探讨[J].细胞与分子免疫学杂志,2005,21(3):356-358. 被引量:10
  • 2王绿化.局部晚期非小细胞肺癌的治疗进展[J].临床肿瘤学杂志,2006,11(5):321-325. 被引量:36
  • 3陈萍,胡平.GP方案联合放疗治疗晚期非小细胞肺癌的临床观察[J].肿瘤基础与临床,2006,19(6):476-477. 被引量:2
  • 4Tsujino K, Hirota S, Endo M, et al. Predictive Value of Dose- Volume Histogram Parameters for Predicting Radiation Pneumonitis after Concurrent Chemoradiation for Lung Cancer[J]. Int J Radiat Oncol Biol Phys, 2003,55 ( 1 ): 110-115.
  • 5Sato Y, Hogg JC, English D, et al. Endothelin-I changes polymorphonuclear lenkocytes's deformability and CD11B expression and promotes their retention in the lung[J]. Am J Respir Cell Mol Biol,2000,23(3):404-410.
  • 6Jain R, Shaul PW, Borok Z, et al. Endothelin-I Induces Alveolar EMT Through ET-A-mediated Production of Transforming Growth Factor-β1 [J]. Am J Respir Cell Mol Biol,2007,37(1) : 38-47.
  • 7Shi Wen X,Chen Y, Denton CP, et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rae/ phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the ehhanced contractile phenotype of fibrotic fibroblasts[J]. Am J Mol Biol Cell,2004,15(6) :2707-2719.
  • 8Rubin P, Finkelstein J, Shapiro D, et al. Molecular biologymechanisms in the radiation Induction of pulmonary injury syndromes:interrelationship between the alveolar macrophage and the septal fibroblast[J].Int J Radiat Oncol Biol Phys, 1992,24 (1):93-101.
  • 9Claude L, Perol D, Ginestet C, et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer. Clinical and dosimetric factors analysis[J]. Radiother Oncol,2004,71 (2) : 175.
  • 10Inoue A,Kunitoh H, Sekine I, et al. Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long term prognosis[J]. Int J Radiat Oncol Biol Phys, 2001,49(3) :649.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部